Mexico

U.S.-Mexico Border Health Commission
UABC / COLEF / Universidad Xochicalco

Through the U.S.-Mexico Border Health Commission, opportunities exist for GloCal fellows to conduct research in the border region in affiliation with Universidad Autónoma de Baja California (UABC), El Colegio de la Frontera Norte (COLEF) and Universidad Xochicalco through one of the following projects:

La Frontera: NIDA-funded study of HIV, HCV, SARS-CoV-2 and cross-border mobility among people who inject drugs. PIs: Steffanie Strathdee (UCSD) and Gudelia Rangel (Mexico-U.S. Border Health Commission).   

Proyecto EPICO: Study of HIV, TB, and SARS-CoV-2 among migrants in Tijuana. PIs: Steffanie Strathdee, Richard Garfein and Constance Benson (UCSD); Jaime Sepulveda (UCSF), Ietza Bojorquez (COLEF); Rafael Laniado (Tijuana General Hospital). 

Drug tourism networks and HIV/COV-2 transmission along the U.S./Mexico Border: CFAR- funded study to assess the impact of drug tourism networks on HIV outcomes (i.e. engagement in services and HIV incidence) in the San Diego and Tijuana border region, and how border restrictions in the era of SARS-CoV-2 affect network dynamics as a structural driver of HIV risk. The study is led by Britt Skaathun (UCSD) and investigators include Steffanie Strathdee, Antoine Chaillon, Annick Borquez, and Tetyana Vasylveva at UCSD; Gudelia Rangel (U.S. Mexico Border Health Commission), and Alicia Vera (UCSD and U.S. Mexico Border Health Commission).

Developing a community informed psychosocial intervention for women who inject drugs in Mexicali, Mexico: NIMH-CHIPTS funded formative pilot study to collect qualitative and quantitative data from women who use the services at Mexicali’s safe consumption site.  PIs: David Goodman (UCLA) and Jaime Arredondo (Centro de Investigación y Docencia Económicas).


Site contact: Dr. Steffanie Strathdee